Unicycive Therapeutics (UNCY) Net Income Growth (3y) (2023 - 2026)
Unicycive Therapeutics (UNCY) Net Income Growth (3y) (2023 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
32.96% |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
30.59% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-46.86% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
19.97% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
13.80% |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Unicycive Therapeutics |
159.47 Mn |
104.88 Mn |
- |
-24.18% |
| Date | Value |
|---|
| Mar 31, 2026 |
-24.18% |
| Dec 31, 2025 |
-9.00% |
| Sep 30, 2025 |
-8.40% |
| Jun 30, 2025 |
-23.33% |
| Mar 31, 2025 |
-30.04% |
| Dec 31, 2024 |
-48.25% |
| Sep 30, 2024 |
-7.04% |
| Jun 30, 2024 |
-84.91% |
| Mar 31, 2024 |
-110.39% |
| Dec 31, 2023 |
-91.62% |
| Sep 30, 2023 |
-101.33% |
| Jun 30, 2023 |
-130.14% |
